Combination therapy with low-frequency ultrasound irradiation and radiofrequency ablation as a synergistic treatment for pancreatic cancer

We aim to evaluate the efficacies of combination therapy with low-frequency ultrasound-stimulated microbubbles (USMB) and radiofrequency ablation (RFA) on suppressing the proliferation of pancreatic cancer cell and treating Panc02 subcutaneous xenograft mice. The proliferation of HPDE6-C7 and Panc02...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Huiyang Wang, Wenxiu Ding, Hongwei Shi, Haiwei Bao, Yuting Lu, Tian an Jiang
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
Acceso en línea:https://doaj.org/article/d2e3617b830d4423b250c65fa8e7bac5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d2e3617b830d4423b250c65fa8e7bac5
record_format dspace
spelling oai:doaj.org-article:d2e3617b830d4423b250c65fa8e7bac52021-11-04T15:51:54ZCombination therapy with low-frequency ultrasound irradiation and radiofrequency ablation as a synergistic treatment for pancreatic cancer2165-59792165-598710.1080/21655979.2021.1995581https://doaj.org/article/d2e3617b830d4423b250c65fa8e7bac52021-10-01T00:00:00Zhttp://dx.doi.org/10.1080/21655979.2021.1995581https://doaj.org/toc/2165-5979https://doaj.org/toc/2165-5987We aim to evaluate the efficacies of combination therapy with low-frequency ultrasound-stimulated microbubbles (USMB) and radiofrequency ablation (RFA) on suppressing the proliferation of pancreatic cancer cell and treating Panc02 subcutaneous xenograft mice. The proliferation of HPDE6-C7 and Panc02 cells after the treatment of USMB and RFA alone or combination were evaluated by CCK-8 assay. Scratch test was performed to assess the cell migration capability. Panc02-bearing mice were received 14-day treatment of USMB and RFA alone or combination. Tumor size and survival rate was recorded once two days. The serum levels of immune-related factors and changes of apoptosis- and autophagy-related factors were detected by ELISA and western blotting methods. As a results, CKK-8 assays revealed significant inhibition on Panc02 cell proliferation in combination therapy with USMB and RFA relative to other groups (all p < 0.05). Strong synergistic effect of USMB combined with RFA was confirmed via the calculated combination index (CI) <0.4. In addition, combination therapy of USMB and RFA significantly inhibited the migration of Panc02 cells. Moreover, combined treatment remarkably inhibited the size and width of xenograft and improved the survival in Panc02-bearing mice. Furthermore, 14-day combination therapy of USMB and RFA in Panc02-bearing mice significantly facilitated the apoptosis and autophagy of tumor cells. In summary, combination therapy of USMB and RFA showed synergistic anti-tumor efficacies on Panc02 cells attributing to the promotion on apoptosis and autophagy in Panc02 subcutaneous xenograft mice.Huiyang WangWenxiu DingHongwei ShiHaiwei BaoYuting LuTian an JiangTaylor & Francis Grouparticlelow-frequency ultrasound-stimulated microbubblesradiofrequency ablationcombined treatmentpanc02 cellapoptosisautophagyBiotechnologyTP248.13-248.65ENBioengineered, Vol 0, Iss 0 (2021)
institution DOAJ
collection DOAJ
language EN
topic low-frequency ultrasound-stimulated microbubbles
radiofrequency ablation
combined treatment
panc02 cell
apoptosis
autophagy
Biotechnology
TP248.13-248.65
spellingShingle low-frequency ultrasound-stimulated microbubbles
radiofrequency ablation
combined treatment
panc02 cell
apoptosis
autophagy
Biotechnology
TP248.13-248.65
Huiyang Wang
Wenxiu Ding
Hongwei Shi
Haiwei Bao
Yuting Lu
Tian an Jiang
Combination therapy with low-frequency ultrasound irradiation and radiofrequency ablation as a synergistic treatment for pancreatic cancer
description We aim to evaluate the efficacies of combination therapy with low-frequency ultrasound-stimulated microbubbles (USMB) and radiofrequency ablation (RFA) on suppressing the proliferation of pancreatic cancer cell and treating Panc02 subcutaneous xenograft mice. The proliferation of HPDE6-C7 and Panc02 cells after the treatment of USMB and RFA alone or combination were evaluated by CCK-8 assay. Scratch test was performed to assess the cell migration capability. Panc02-bearing mice were received 14-day treatment of USMB and RFA alone or combination. Tumor size and survival rate was recorded once two days. The serum levels of immune-related factors and changes of apoptosis- and autophagy-related factors were detected by ELISA and western blotting methods. As a results, CKK-8 assays revealed significant inhibition on Panc02 cell proliferation in combination therapy with USMB and RFA relative to other groups (all p < 0.05). Strong synergistic effect of USMB combined with RFA was confirmed via the calculated combination index (CI) <0.4. In addition, combination therapy of USMB and RFA significantly inhibited the migration of Panc02 cells. Moreover, combined treatment remarkably inhibited the size and width of xenograft and improved the survival in Panc02-bearing mice. Furthermore, 14-day combination therapy of USMB and RFA in Panc02-bearing mice significantly facilitated the apoptosis and autophagy of tumor cells. In summary, combination therapy of USMB and RFA showed synergistic anti-tumor efficacies on Panc02 cells attributing to the promotion on apoptosis and autophagy in Panc02 subcutaneous xenograft mice.
format article
author Huiyang Wang
Wenxiu Ding
Hongwei Shi
Haiwei Bao
Yuting Lu
Tian an Jiang
author_facet Huiyang Wang
Wenxiu Ding
Hongwei Shi
Haiwei Bao
Yuting Lu
Tian an Jiang
author_sort Huiyang Wang
title Combination therapy with low-frequency ultrasound irradiation and radiofrequency ablation as a synergistic treatment for pancreatic cancer
title_short Combination therapy with low-frequency ultrasound irradiation and radiofrequency ablation as a synergistic treatment for pancreatic cancer
title_full Combination therapy with low-frequency ultrasound irradiation and radiofrequency ablation as a synergistic treatment for pancreatic cancer
title_fullStr Combination therapy with low-frequency ultrasound irradiation and radiofrequency ablation as a synergistic treatment for pancreatic cancer
title_full_unstemmed Combination therapy with low-frequency ultrasound irradiation and radiofrequency ablation as a synergistic treatment for pancreatic cancer
title_sort combination therapy with low-frequency ultrasound irradiation and radiofrequency ablation as a synergistic treatment for pancreatic cancer
publisher Taylor & Francis Group
publishDate 2021
url https://doaj.org/article/d2e3617b830d4423b250c65fa8e7bac5
work_keys_str_mv AT huiyangwang combinationtherapywithlowfrequencyultrasoundirradiationandradiofrequencyablationasasynergistictreatmentforpancreaticcancer
AT wenxiuding combinationtherapywithlowfrequencyultrasoundirradiationandradiofrequencyablationasasynergistictreatmentforpancreaticcancer
AT hongweishi combinationtherapywithlowfrequencyultrasoundirradiationandradiofrequencyablationasasynergistictreatmentforpancreaticcancer
AT haiweibao combinationtherapywithlowfrequencyultrasoundirradiationandradiofrequencyablationasasynergistictreatmentforpancreaticcancer
AT yutinglu combinationtherapywithlowfrequencyultrasoundirradiationandradiofrequencyablationasasynergistictreatmentforpancreaticcancer
AT tiananjiang combinationtherapywithlowfrequencyultrasoundirradiationandradiofrequencyablationasasynergistictreatmentforpancreaticcancer
_version_ 1718444741900632064